[HTML][HTML] Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
O Dogar, A Keding, R Gabe, AM Marshall… - The Lancet Global …, 2020 - thelancet.com
Background Smoking cessation is important in patients with tuberculosis because it can
reduce the high rates of treatment failure and mortality. We aimed to assess the …
reduce the high rates of treatment failure and mortality. We aimed to assess the …
[PDF][PDF] Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
OF Dogar, A Keding, R Gabe… - The Lancet Global …, 2020 - eprints.whiterose.ac.uk
Background Smoking cessation is important in patients with tuberculosis because it can
reduce the high rates of treatment failure and mortality. We aimed to assess the …
reduce the high rates of treatment failure and mortality. We aimed to assess the …
Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
O Dogar, A Keding, R Gabe… - The Lancet …, 2020 - cris.maastrichtuniversity.nl
Background Smoking cessation is important in patients with tuberculosis because it can
reduce the high rates of treatment failure and mortality. We aimed to assess the …
reduce the high rates of treatment failure and mortality. We aimed to assess the …
Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
TB and Tobacco Consortium - The Lancet Global Health, 2020 - research.ed.ac.uk
BACKGROUND: Smoking cessation is important in patients with tuberculosis because it can
reduce the high rates of treatment failure and mortality. We aimed to assess the …
reduce the high rates of treatment failure and mortality. We aimed to assess the …
Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
O Dogar, A Keding, R Gabe… - The Lancet …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Smoking cessation is important in patients with tuberculosis because it can
reduce the high rates of treatment failure and mortality. We aimed to assess the …
reduce the high rates of treatment failure and mortality. We aimed to assess the …
[HTML][HTML] Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
O Dogar, A Keding, R Gabe, AM Marshall… - The Lancet Global …, 2020 - Elsevier
Background Smoking cessation is important in patients with tuberculosis because it can
reduce the high rates of treatment failure and mortality. We aimed to assess the …
reduce the high rates of treatment failure and mortality. We aimed to assess the …
[PDF][PDF] Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
OF Dogar, A Keding, R Gabe, A Marshall… - The Lancet Global …, 2020 - pure.york.ac.uk
Background Smoking cessation is important in patients with tuberculosis because it can
reduce the high rates of treatment failure and mortality. We aimed to assess the …
reduce the high rates of treatment failure and mortality. We aimed to assess the …
Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
O Dogar, A Keding, R Gabe, AM Marshall, R Huque… - 2020 - cabidigitallibrary.org
Background: Smoking cessation is important in patients with tuberculosis because it can
reduce the high rates of treatment failure and mortality. We aimed to assess the …
reduce the high rates of treatment failure and mortality. We aimed to assess the …
Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
O Dogar, A Keding, R Gabe, AM Marshall… - The Lancet. Global …, 2020 - europepmc.org
Background Smoking cessation is important in patients with tuberculosis because it can
reduce the high rates of treatment failure and mortality. We aimed to assess the …
reduce the high rates of treatment failure and mortality. We aimed to assess the …
[PDF][PDF] Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
O Dogar, A Keding, R Gabe, AM Marshall, R Huque… - 2020 - researchgate.net
Background Smoking cessation is important in patients with tuberculosis because it can
reduce the high rates of treatment failure and mortality. We aimed to assess the …
reduce the high rates of treatment failure and mortality. We aimed to assess the …